$AIP

Viana Antonio J sold $174K of AIP (indirect holdings)

Viana Antonio J sold 4,900 indirectly-held shares of Arteris, Inc. (AIP) at $35.47 ($0.17M total) on 2026-06-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Viana Antonio J
Published Jun 5, 2026, 10:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 5, 2026, 10:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AIP
Neutral
medium confidence
Mentioned
$AIP
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIPNeutralLow
01

Why it matters

The disclosure provides a datapoint on insider behavior but does not introduce new fundamentals, guidance, or legal/contract developments.

02

Market read

Traders may briefly reassess sentiment around AIP, but the 10b5-1 framing suggests limited incremental information.

03

What to watch

Check whether there are multiple recent Form 4s (buys vs sells) and whether the director’s remaining stake meaningfully changes over time.

Relevance 6/10Novelty 5/10Timing: Filed today; sale occurred 2026-06-04 and is disclosed 2026-06-05.

Background

SEC Form 4 insider transaction disclosure for Arteris, Inc. (AIP).

Company-level read

Ticker impact

$AIPNeutralMedium confidence
Context

Arteris director Viana Antonio J sold 4,900 shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Low probability of sustained price impact; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a routine insider transaction with a stated 10b5-1 plan, and no new operating/financial catalyst is provided.

Market effects

Minimal—this is company-specific insider activity with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity rather than bearish conviction.

Key entities

  • Arteris, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Viana Antonio J

    Director who sold 4,900 shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AIPMedAI 8/10

Arteris (AIP) Q2 2026 Earnings Call Transcript

Arteris, Inc. (AIP) reported Q2 2026 revenue of $24.1 million, up 46% year over year. ACV plus royalties were $99.5 million, up 44%, and remaining performance obligation was $135 million, up 36%. Cash and investments rose to $123 million after an at-the-market raise. Full-year 2026 revenue guidance was raised to $95-$98 million.

MedAI 8/10

Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

$AIPHighAI 9/10

Arteris, Inc. (AIP): Results of Operations and Financial Condition

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, to